| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 73815-11-9 | Cimoxatone |
≥98% | | 询价 |
| 2 | 33404-57-8 | Dunnione |
≥98% | | 询价 |
| 3 | 77-53-2 | Cedrol |
≥98% | | 询价 |
| 4 | 811435-10-6 | Polymyxin B1-i |
≥98% | | 询价 |
| 5 | 156161-89-6 | BQ788 sodium salt |
≥98% | | 询价 |
| 6 | 9002-86-2 | Polyvinyl chloride |
≥98% | | 询价 |
| 7 | 1807512-46-4 | Mal-PEG5-PFP |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 15382-69-1 | m-Anisidine,4-(3-heptenyloxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 15382-68-0 | m-Anisidine,4-((3-ethylheptyl)oxy)-,hydrochloride |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 15382-66-8 | m-Anisidine,4-(2-ethylbutoxy)-,hydrobromide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 15382-67-9 | m-Anisidine,4-((1-methylheptyl)oxy)-,hydrochloride |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 109808-49-3 | m-Anisamide,N-(5-(p-aminophenoxy)pentyl)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 135306-39-7 | Manifaxine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 1392-28-5 | Mandelonitrile primeveroside |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | | MGR1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 4242-46-0 | Mandelonitrile benzoate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 90-64-2 | Mandelic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 8018-01-7 | Mancozeb |
≥98% | | 询价 |
| 19 | 102-28-3 | m-Aminoacetanilide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | 60394-92-5 | Mamanine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 880759-65-9 | Naloxonazine dihydrochloride |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | 688013-96-9 | Malyl tyrosine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 1485456-25-4 | Mal-RP |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 2055048-43-4 | Mal-PEG8-t-butyl ester |
≥98% | | 询价 |
| 25 | 2055033-05-9 | Mal-PEG8-NHS ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 1818294-46-0 | Mal-PEG8-acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | 518044-37-6 | Mal-PEG6-t-butyl ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 1599486-33-5 | Mal-PEG6-PFP |
≥98% | | 询价 |
| 29 | 1599472-25-9 | Mal-PEG6-NHS ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 518044-42-3 | Mal-PEG6-acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 105788-17-8 | m-Anisidine,4-(4-pentenyloxy)-,hydrobromide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 131505-02-7 | PD 130908 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 107276-40-4 | m-Anisidine,4-(3-(p-methoxyphenoxy)propoxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 15382-73-7 | m-Anisidine,4-(3-phenylpropoxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 15382-87-3 | m-Anisidine,4-(3-phenoxypropoxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 909664-41-1 | BPU-11 |
≥98% | | 询价 |
| 37 | 1802665-43-5 | BPTQ |
≥98% | | 询价 |
| 38 | 139968-49-3 | Metaflumizone |
≥98% | | 询价 |
| 39 | 26719-50-6 | 1,4-Butanediol bisdecanoate |
≥98% | | 询价 |
| 40 | 776-88-5 | 1,3-Dioxane,5,5-dimethyl-2-phenyl- |
≥98% | | 询价 |
| 41 | 1120-97-4 | 1,3-Dioxane,4-methyl- |
≥98% | | 询价 |
| 42 | 7401-30-1 | 1,3-Dioxane,2-(p-chlorophenyl)-5-methyl-5-nitro- |
≥98% | | 询价 |
| 43 | 3080-69-1 | 1,3-Dioxane,2-hexyl-4-methyl- |
≥98% | | 询价 |
| 44 | 141434-67-5 | 13-Dihydrodoxorubicin |
≥98% | | 询价 |
| 45 | 17863-69-3 | 1,2-Didecanoylglycerol |
≥98% | | 询价 |
| 46 | 773852-25-8 | 103D5R |
≥98% | | 询价 |
| 47 | 1914989-49-3 | BPN-15606 |
≥98% | | 询价 |
| 48 | 1849590-02-8 | Tomivosertib HCl(eFT-508) |
≥98% | | 询价 |
| 49 | | Tomivosertib 2HCl |
≥98% | | 询价 |
| 50 | 1059677-12-1 | BPH-742 |
≥98% | | 询价 |
| 51 | 946417-21-6 | BPH-675 |
≥98% | | 询价 |
| 52 | 157124-84-0 | BPH-652 potassium |
≥98% | | 询价 |
| 53 | 39391-39-4 | Nocardicin A |
≥98% | | 询价 |
| 54 | 1059677-40-5 | BPH-628 |
≥98% | | 询价 |
| 55 | 108093-90-9 | Probimane |
≥98% | | 询价 |
| 56 | 1426824-36-3 | BPH-1218 |
≥98% | | 询价 |
| 57 | 1638-41-1 | p38 MAP Kinase Inhibitor IV |
≥98% | | 询价 |
| 58 | 143986-17-8 | LZN86178 |
≥98% | | 询价 |
| 59 | 312281-74-6 | BPDBA |
≥98% | | 询价 |
| 60 | 15382-85-1 | m-Anisidine,4-((5-(benzyloxy)pentyl)oxy)-,methanesulfonate |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com